(dairy breeds appearing more susceptible to infection with N. caninum than beef breeds [1] ("not cow infection") occurs in the first trimester of gestation, the outcome is often abortion; 53 transplacental transmission of the parasite is expected to be low in this time of pregnancy . 54
However, calves born from Neospora-positive dams might continue to develop through 55 gestation, and are either born weak, show neurological signs of disease later in development, 56 or can also be completely unaffected [17] . In the latter case, such calves can then, in turn, give 57 birth to N. caninum infected offspring, which are either affected by the disease or not. This 58 complicates the situation immensely, and renders the development of a vaccine, no matter 59 whether a live or a subunit version, a difficult task. A vaccine that can both, prevent abortionlawsuits. Live vaccine production would likely rely on cell-culture-derived organisms the 76 production process of which is labour intensive in its maintenance. Live vaccine production 77 also present challenges in terms of parasite preservation and viability thereafter, although the 78 successful production and distribution of Toxovax® (a live vaccine for the prevention of 79
T. gondii abortions in sheep) shows this is achievable through a "made to order" process. As 80 live vaccines might possibly be expected to result in chronic infection of the host, a residual 81 risk exists that the life cycle could ultimately be completed again, if tissues from vaccinates 82 was to be fed to canid definitive hosts. With Toxovax®, the tachyzoites of T. gondii appear to 83 have lost the ability to encyst (and thus persist) in the vaccinated host; a live vaccine for 84 
